BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37005173)

  • 21. Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.
    Miyamoto Y; Hayashi N; Sakamoto Y; Ohuchi M; Tokunagam R; Kurashige J; Hiyoshi Y; Baba Y; Iwagami S; Yoshida N; Yoshida M; Baba H
    Int J Clin Oncol; 2015 Dec; 20(6):1140-6. PubMed ID: 25947545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma.
    Hagemans JAW; Rothbarth J; van Bogerijen GHW; van Meerten E; Nuyttens JJME; Verhoef C; Burger JWA
    Ann Surg Oncol; 2019 Apr; 26(4):1134-1141. PubMed ID: 30725310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital.
    Bringolf L; Pestalozzi B; Fink D; Dedes K
    Swiss Med Wkly; 2016; 146():w14393. PubMed ID: 28102883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study.
    Chen J; Chen H; Zhao F; Wang Z; Liu Q
    Transl Cancer Res; 2022 Jan; 11(1):171-180. PubMed ID: 35261894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
    Benavides M; Gómez-España A; García-Alfonso P; González CG; Viéitez JM; Rivera F; Safont MJ; Abad A; Sastre J; Valladares-Ayerbes M; Carrato A; González-Flores E; Robles L; Salud A; Alonso-Orduña V; Montagut C; Asensio E; Díaz-Rubio E; Aranda E;
    Eur J Surg Oncol; 2022 May; 48(5):1123-1132. PubMed ID: 34872775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
    Madbouly KM; Abbas KS; Hussein AM
    Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.
    Pasetto LM; Friso ML; Pucciarelli S; Basso U; Toppan P; Rugge M; Sinigaglia G; Nitti D; Sotti G; Monfardini S
    Anticancer Res; 2007; 27(2):1079-85. PubMed ID: 17465247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment strategy for rectal cancer with synchronous metastasis: 65 consecutive Italian cases from the Bologna Multidisciplinary Rectal Cancer Group.
    Pinto C; Pini S; Di Fabio F; Cuicchi D; Iacopino B; Lecce F; Ercolani G; Rojas Llimpe FL; De Raffele E; Stella F; Di Tullio P; Giaquinta S; Pinna AD; Cola B
    Oncology; 2014; 86(3):135-42. PubMed ID: 24504268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy.
    Hsieh MC; Chiang PH; Rau KM; Chen YY; Su YL; Huang CH
    Urol Oncol; 2015 Nov; 33(11):495.e9-495.e14. PubMed ID: 26254698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases.
    Gall TM; Basyouny M; Frampton AE; Darzi A; Ziprin P; Dawson P; Paraskeva P; Habib NA; Spalding DR; Cleator S; Lowdell C; Jiao LR
    Colorectal Dis; 2014 Jun; 16(6):O197-205. PubMed ID: 24344746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does early PET/CT assesment of response to chemotherapy predicts survival in patients with advanced stage non-small-cell lung cancer?
    Ordu C; Selcuk NA; Erdogan E; Angin G; Gural Z; Memis H; Yencilek E; Dalsuna S; Pilanci K
    Medicine (Baltimore); 2014 Dec; 93(28):e299. PubMed ID: 25526475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective survival analysis of stage II-III rectal cancer: tumour regression grade, grading and lymphovascular invasion are the only predictors.
    Morini A; Annicchiarico A; Romboli A; Ricco' M; Crafa P; Montali F; Dell'Abate P; Costi R
    ANZ J Surg; 2021 Mar; 91(3):E112-E118. PubMed ID: 33319510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
    Cai W; Yuan YC; Li MY; Kong W; Dong BJ; Chen YH; Zhang J; Xue W; Huang YR; Zhou LX; Huang JW
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):384-389. PubMed ID: 29860767
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
    Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
    Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer.
    Meng X; Huang Z; Di J; Mu D; Wang Y; Zhao X; Zhao H; Zhu W; Li X; Kong L; Xing L
    Medicine (Baltimore); 2015 Nov; 94(47):e2106. PubMed ID: 26632727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nomogram to predict the prognosis of patients with unresected rectal adenocarcinoma undergoing chemoradiotherapy: a population-based study.
    Liu LL; Sun JD; Xiang ZL
    J Cancer; 2021; 12(16):4745-4761. PubMed ID: 34234846
    [No Abstract]   [Full Text] [Related]  

  • 38. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
    Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
    [No Abstract]   [Full Text] [Related]  

  • 39. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
    He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
    Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study.
    Seddik Y; Brahmi SA; Afqir S
    Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.